Biotech

All Articles

Cullinan, after $25M deal, return bispecific to Harbour

.Cullinan Therapeutics was actually thrilled good enough along with Port BioMed's bispecific invulne...

A more detailed examine Tough Biotech's Strong 15

.In this week's incident of "The Top Pipe," we are actually diving into Strong Biotech's yearly Toug...

Lilly faces stage 2 failing of tau-targeting med

.The confetti is still soaring coming from Eli Lilly's event commemorating the commendation of Alzhe...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of considerable management hirings, firings and ...

Lykos will ask FDA to reexamine its decision observing turndown of MDMA therapy for trauma

.Observing a bad presenting for Lykos Therapeutics' MDMA applicant for trauma at a recent FDA consul...

AN 2 one-halfs census, quits period 3 trial after information disappoint

.AN2 Therapies is reassessing its company in reaction to uninspired midphase data, swearing to lay o...

Merck pays for $700M for bispecific, snooping autoimmune position as well as odds to test Amgen in cancer

.Merck &amp Co. is actually spending $700 thousand upfront to challenge Amgen in a blood cancer cell...

Gilead spends J&ampJ $320M to exit licensing package for seladelpar

.Along With Gilead Sciences about to an FDA selection for its own liver disease medicine seladelpar,...

' All hands on deck' at Lilly as peers target obesity market

.Chief executive officer David Ricks can easily view the companies establishing camping tents at bas...

Entero giving up staff, abandoning workplace and also stopping briefly R&ampD

.Mattress Liquidators has switched Entero Therapeutics white as a slab. The collector ordered Entero...